This article is available to subscribers. Subscribe now. Already have an account? Sign in

Original ArticleFree PreviewArchive

Prevention of Nitroprusside-Induced Cyanide Toxicity with Hydroxocobalamin

List of authors.
  • James E. Cottrell, M.D.,
  • Pierre Casthely, M.D.,
  • Jonathan D. Brodie, Ph.D., M.D.,
  • Katie Patel, M.D.,
  • Anne Klein,
  • and Herman Turndorf, M.D.

Abstract

To investigate hydroxocobalamin's role in preventing cyanide intoxication from sodium nitroprusside, we studied two groups of patients. One group received nitroprusside alone, and the other received nitroprusside and hydroxocobalamin. Red-cell and plasma cyanide levels were 83.44± 23.12 and 3.51±1.01 μg 100 ml after nitroprusside alone and were 33.18±17.29 and 2.18±0.65 μg per 100 ml after nitroprusside plus hydroxocobalamin. Acidosis developed in patients with red-cell cyanide levels higher than 75 μg per 100 ml. When hydroxocobalamin infusion was stopped before sodium nitroprusside infusion was discontinued, blood cyanide levels and base deficit increased in a manner similar to that in the untreated group. The dose of nitroprusside used in each group did not differ statistically. These data show that hydroxocobalamin prevents cyanide transfer from red cells and plasma to tissue after nitroprusside metabolism, and thereby prevents cyanide toxicity from large intravenous doses of the drug. (N Engl J Med 298:809–811, 1978)

Author Affiliations

From the departments of Anesthesiology and Psychiatry, New York University Medical Center, and the Department of Anesthesiology, Bellevue Hospital Center (address reprint requests to Dr. Cottrell at the Department of Anesthesiology, New York University Medical Center, 560 First Ave., New York, NY 10016).

Print Subscriber? Activate your online access.